135 related articles for article (PubMed ID: 26560105)
1. Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
Raben D; Mocroft A; Rayment M; Mitsura VM; Hadziosmanovic V; Sthoeger ZM; Palfreeman A; Morris S; Kutsyna G; Vassilenko A; Minton J; Necsoi C; Estrada VP; Grzeszczuk A; Johansson VS; Begovac J; Ong EL; Cabié A; Ajana F; Celesia BM; Maltez F; Kitchen M; Comi L; Dragsted UB; Clumeck N; Gatell J; Gazzard B; d'Arminio Monforte A; Rockstroh J; Yazdanpanah Y; Champenois K; Jakobsen ML; Sullivan A; Lundgren JD;
PLoS One; 2015; 10(11):e0140845. PubMed ID: 26560105
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study).
Sullivan AK; Raben D; Reekie J; Rayment M; Mocroft A; Esser S; Leon A; Begovac J; Brinkman K; Zangerle R; Grzeszczuk A; Vassilenko A; Hadziosmanovic V; Krasnov M; Sönnerborg A; Clumeck N; Gatell J; Gazzard B; Monforte Ad; Rockstroh J; Lundgren JD
PLoS One; 2013; 8(1):e52845. PubMed ID: 23341910
[TBL] [Abstract][Full Text] [Related]
3. Indicator disease-guided testing for HIV--the next step for Europe?
Gazzard B; Clumeck N; d'Arminio Monforte A; Lundgren JD
HIV Med; 2008 Jul; 9 Suppl 2():34-40. PubMed ID: 18557871
[TBL] [Abstract][Full Text] [Related]
4. Comparison of two HIV testing strategies in primary care centres: indicator-condition-guided testing vs. testing of those with non-indicator conditions.
Menacho I; Sequeira E; Muns M; Barba O; Leal L; Clusa T; Fernandez E; Moreno L; Raben D; Lundgren J; Gatell JM; Garcia F; Cayuelas L; Aragunde V; Vergara M; Catalan M; Moreno MA; Hormigo G; Siso A; Herreras Z; Sebastian L; Benito L; Picas A; Hoyo J; Giner MJ; Cararach D; Moles E; Moro ML; Arrabal P; Roca D; Prego S; Ferrer X; Egido A; Ventosa C; Garcia S; Muñoz S; Massana A; Sole J; Curiel M; Heras F; Leon A
HIV Med; 2013 Oct; 14 Suppl 3():33-7. PubMed ID: 24033901
[TBL] [Abstract][Full Text] [Related]
5. National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review.
Jordans CCE; Vasylyev M; Rae C; Jakobsen ML; Vassilenko A; Dauby N; Grevsen AL; Jakobsen SF; Raahauge A; Champenois K; Papot E; Malin JJ; Boender TS; Behrens GMN; Gruell H; Neumann A; Spinner CD; Valbert F; Akinosoglou K; Kostaki EG; Nozza S; Giacomelli A; Lapadula G; Mazzitelli M; Torti C; Matulionyte R; Matulyte E; Van Welzen BJ; Hensley KS; Thompson M; Ankiersztejn-Bartczak M; Skrzat-Klapaczyńska A; Săndulescu O; Streinu-Cercel A; Streinu-Cercel A; Miron VD; Pokrovskaya A; Hachfeld A; Dorokhina A; Sukach M; Lord E; Sullivan AK; Rokx C;
Euro Surveill; 2022 Dec; 27(48):. PubMed ID: 36695464
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions.
Lord E; Stockdale AJ; Malek R; Rae C; Sperle I; Raben D; Freedman A; Churchill D; Lundgren J; Sullivan AK;
HIV Med; 2017 Apr; 18(4):300-304. PubMed ID: 27535357
[TBL] [Abstract][Full Text] [Related]
7. Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study - 2012 - 2015.
Raben D; Sullivan AK; Mocroft A; Kutsyna G; Hadžiosmanović V; Vassilenko A; Chkhartisvili N; Mitsura V; Pedersen C; Anderson J; Begovac J; Bak Dragsted U; Bertisch B; Grzeszczuk A; Minton J; Necsoi VC; Kitchen M; Ajana F; Sokhan A; Comi L; Farazmand P; Pesut D; De Wit S; Gatell JM; Gazzard B; d'Arminio Monforte A; Rockstroh JK; Yazdanpanah Y; Champenois K; Jakobsen ML; Lundgren JD;
PLoS One; 2019; 14(8):e0220108. PubMed ID: 31408476
[TBL] [Abstract][Full Text] [Related]
8. Promoting HIV indicator condition-guided testing in hospital settings (PROTEST 2.0): study protocol for a multicentre interventional study.
Bogers SJ; Schim van der Loeff MF; Davidovich U; Boyd A; van der Valk M; Brinkman K; de Bree GJ; Reiss P; van Bergen JEAM; Geerlings SE;
BMC Infect Dis; 2021 Jun; 21(1):519. PubMed ID: 34078315
[TBL] [Abstract][Full Text] [Related]
9. The late-presenting HIV-infected patient 30 years after the introduction of HIV testing: spectrum of opportunistic diseases and missed opportunities for early diagnosis.
Tominski D; Katchanov J; Driesch D; Daley MB; Liedtke A; Schneider A; Slevogt H; Arastéh K; Stocker H
HIV Med; 2017 Feb; 18(2):125-132. PubMed ID: 27478058
[TBL] [Abstract][Full Text] [Related]
10. Earlier testing for HIV--how do we prevent late presentation?
Yazdanpanah Y; Lange J; Gerstoft J; Cairns G
Antivir Ther; 2010; 15 Suppl 1():17-24. PubMed ID: 20442457
[TBL] [Abstract][Full Text] [Related]
11. Tracking missed opportunities for an early HIV diagnosis in a population of people living with HIV with known time of infection.
Basoulis D; Kostaki EG; Paraskevis D; Hatzakis A; Psichogiou M
Sex Transm Infect; 2022 Mar; 98(2):79-84. PubMed ID: 33608478
[TBL] [Abstract][Full Text] [Related]
12. Missed opportunities for earlier HIV diagnosis in an emergency department despite an HIV screening program.
White DA; Warren OU; Scribner AN; Frazee BW
AIDS Patient Care STDS; 2009 Apr; 23(4):245-50. PubMed ID: 19260771
[TBL] [Abstract][Full Text] [Related]
13. Falling through the cracks? Missed opportunities for earlier HIV diagnosis in a New York City Hospital.
Nakao JH; Wiener DE; Newman DH; Sharp VL; Egan DJ
Int J STD AIDS; 2014 Oct; 25(12):887-93. PubMed ID: 24535693
[TBL] [Abstract][Full Text] [Related]
14. Assessment of HIV testing recommendations in Greek specialty guidelines: A missed opportunity and room for improvement for recommending testing.
Akinosoglou K; Kostaki EG; Paraskevis D; Gogos CA
AIDS Care; 2021 Oct; 33(10):1312-1315. PubMed ID: 33678071
[TBL] [Abstract][Full Text] [Related]
15. Optimal HIV testing and earlier care: the way forward in Europe.
Coenen T; Lundgren J; Lazarus JV; Matic S
HIV Med; 2008 Jul; 9 Suppl 2():1-5. PubMed ID: 18557862
[TBL] [Abstract][Full Text] [Related]
16. HIV testing strategies across European countries.
Mounier-Jack S; Nielsen S; Coker RJ
HIV Med; 2008 Jul; 9 Suppl 2():13-9. PubMed ID: 18557864
[TBL] [Abstract][Full Text] [Related]
17. Review of HIV testing recommendations in Australian specialty guidelines for HIV indicator conditions: a missed opportunity for recommending testing?
Lin YD; Eades L; Nair A; Korman TM; Woolley I
Intern Med J; 2020 Mar; 50(3):293-298. PubMed ID: 31566841
[TBL] [Abstract][Full Text] [Related]
18. The case for indicator condition-guided HIV screening.
Lazarus JV; Hoekstra M; Raben D; Delpech V; Coenen T; Lundgren JD;
HIV Med; 2013 Aug; 14(7):445-8. PubMed ID: 23480600
[TBL] [Abstract][Full Text] [Related]
19. HIV testing in patients presenting with indicator conditions in outpatient settings: offer and uptake rates, and educational and active interventions.
Youssef E; Sanghera T; Bexley A; Hayes M; Perry N; Dosekun O; Perera S
Int J STD AIDS; 2018 Nov; 29(13):1289-1294. PubMed ID: 29979144
[TBL] [Abstract][Full Text] [Related]
20. HIV testing in emergency departments: a recommendation with missed opportunities.
Hardwicke R; Malecha A; Lewis ST; Grimes RM
J Assoc Nurses AIDS Care; 2008; 19(3):211-8. PubMed ID: 18457762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
